2026Year6Month22On the day, the 4th China International Supply Chain Promotion Expo opened at the Shunyi Hall of the China International Exhibition Center in Beijing. As the sole medical enterprise in the Artificial Intelligence Zone of the 4th China International Supply Chain Promotion Expo, Medtronic, under the theme “Smart Healthcare, Co-creating Vitality,” comprehensively presentedAIIndustry Practices and Local Innovation Achievements in Empowering the Medical Value Chain with Digital Intelligence Technologies.

"Rooted in China37“Over the years, Medtronic has remained committed to leveraging innovation as its engine, transitioning from an ‘importer of innovative technologies’ to a ‘co-builder of the local ecosystem.’ The Supply Chain Expo has provided a significant opportunity for this transformation,” said Gu Yushao, Global Senior Vice President and President of Greater China at Medtronic.

Centered on this strategic direction,6Month24On this day, Medtronic held the event “Igniting Local Innovation Engines, Building an Open and Collaborative Ecosystem” at the current Chain Expo venue—Beijing Digital Medical Innovation Base“Digital Intelligence Engine” Lighting Ceremony and Launch of the Co-construction of Medical Innovation Ecosystem

This is not Medtronic’s first participation in the Chain Expo, but this time holds greater significance. InAIAs digital-intelligence technologies sweep across the entire healthcare value chain, the strategic imperative in the Chinese market is evolving, and Medtronic is redefining its local role in China.

At the event, Cao Shan, Vice President of Corporate Affairs and Communications for Medtronic Greater China, stated in her opening remarks:“Medtronic, as a global leader in medical technology, has keenly recognizedAIThe broad prospects of technology reshaping the healthcare value chain, and actively engaging in it, committed to becoming a driver and shaper of this transformation.”

01

Digital Intelligence Penetrates the Entire Medical Value Chain

China Becomes a Launchpad for Frontier Technologies

The digital and intelligent solutions showcased by Medtronic at this event are a concentrated embodiment of this insight. The exhibits cover multiple core disease areas, including cardiovascular, ear, nose, and throat (ENT), and neuromodulation, integratingAI Capabilities are embedded throughout the complete preoperative, intraoperative, and postoperative diagnostic and treatment chain, accelerating the extension from a core focus on single-disease treatment to a full-cycle health product management model covering “prevention–diagnosis–treatment–rehabilitation–management.”

Transcatheter Heart Valve ReplacementAIAssistant, is a product developed by Medtronic and its local partners. It relies onAIPowerful computing capabilities are designed to simulate complex surgical procedures in advance, predict intraoperative risks, and customize individualized diagnosis and treatment plans, thereby enhancing the efficiency of these high-difficulty interventional surgeries and optimizing patients’ real-world experience throughout the entire care journey.

Transcatheter Heart Valve ReplacementAIAssistant

CathWorks FFRangioSystem*Based onAIEmpowerment: Aiming to Optimize Key Indicators in Coronary Artery Stent Implantation SurgeryFFR(Fractional Flow Reserve) testing. From the common average20-minute invasive testing, changed to4minute non-invasive, non-hyperemic pharmacological assessment, and based on3Coronary Angiography: Calculation and Generation of the Full Coronary Artery TreeFFRvalue. It objectively shortens the operative time and, in theory, reduces procedural risks and patient burden.

CathWorks FFR angioSystem

Medtronic Cardiac Rhythm Digital Follow-up ManagerWithAIEmpowering Medtronic’s remote monitoring system for cardiac implantable electronic devices, specifically launched for Chinese patients to enhance the convenience of self-management for those with arrhythmias. While preserving physicians’ decision-making authority, the system reduces the burden of monitoring and management on clinicians, thereby facilitating a shift in post-operative arrhythmia care from “episodic visits” to “lifecycle health management” with active patient participation.

Lin Song, Vice President of Medtronic’s Cardiac Rhythm and Heart Ablation Business Team in China, and Head of the Shared Functions for the Cardiovascular Business Portfolio in China, stated when discussing the full-course management of cardiac rhythm disorders:“Patients with cardiac rhythm disorders inDuring long-term postoperative follow-up, issues such as poor compliance and delayed data feedback are common. Medtronic’s intelligent arrhythmia managementFollow-up Manager, withAI"Empower the remote follow-up system to enhance the convenience of patients' self-management of diseases."

Medtronic Cardiac Rhythm Digital Intelligence Manager

If the aforementioned products provide decision support to physicians within the operating room,Percept™ RCThis represents a deeper involvement of AI in the treatment of neurological disorders.

As the world's first AI-integrated brain-computer interface product,Percept™RC Achieves a Milestone Breakthrough in Deep Brain Stimulation Therapy. This rechargeable, sensing-enabled closed-loop deep brain stimulator can real-time perceive and analyze the electroencephalographic activity of patients with neurological disorders such as Parkinson's disease, dynamically adjusting stimulation parameters in response to changes in their condition. Four words summarize its mode of operation:Brain Reading – Interpretation – Feedback – Healing。The device is no longer merely a mechanism that executes pre-programmed instructions, but a closed-loop system that continuously responds to neural signals. This product has now been formally introduced into clinical use in China, making the country one of the most important settings for the clinical implementation of this cutting-edge technology.

Percept™ RCImplantable Rechargeable Deep Brain Stimulator

Stealth Station FLEX ENTNavigation SystemCommitted to Empowering Precision ENT Surgery with Digital Intelligence: Utilizing Digital Intelligence Technologies for Preoperative Surgical Site3DModeling, and helping doctors accurately plan surgical paths in advancePath;When performing surgeries in complex, high-risk areas such as the skull base and paranasal sinuses, surgeons utilize the StealthStation ENT Navigation System. Functioning as a “GPS” during surgery, it real-time aligns preoperative 3D imaging with instrument positioning, enabling surgeons to clearly visualize the relative positions of instruments in relation to critical blood vessels and target tissues beyond the limited endoscopic field of view, thereby more precisely avoiding “no-go zones.”

Chen Yonghai, Senior Director of Medtronic China’s ENT Business Unit, shared Medtronic’s end-to-end practices in the field of ear, nose, and throat (ENT) care, spanning from preoperative to postoperative stages, at the event. He stated, “Digital intelligence is not just about assisting physicians with planning; itAlsoTransforming the Way Doctors and Patients Communicate. For example, the StealthStation FLEX ENT navigation system allows patientsFrom “Incomprehensible” to “Understandable,” From Blind Trust in Surgery to Rational Decision-Making。“This is a very tangible and human-centric value brought about by digital intelligence.”

Stealth Station FLEX ENTNavigation System

02

From Manufacturing to Reverse Technology Transfer

Local Innovation Takes Root Globally

If digital intelligence is the engine, then localization is the chassis. From“From ‘Exporter of Innovative Technologies’ to ‘Co-builder of the Local Ecosystem’: Medtronic’s localization strategy has entered a new phase, driving the transition from ‘Made in China’ to ‘Created in China.’”

2025Year-end,Medtronic's First Digital Health Innovation Hub in China (BDIC）Put into operation at the Beijing International Pharmaceutical Innovation Park.As a key platform connecting industry chain partners, research institutions, and clinical experts，Leveraging Beijing’s leading medical resources and innovation momentum, we collaborate with partners to explore patient-centric digital-intelligent healthcare innovation models. We provide practical pathways for the promotion and replication of digital healthcare models, contributing to the development of a Chinese solution with global demonstrative significance.

Sun Xiaoyu, Vice President of Regional IT Services, Medtronic Greater ChinaAt the Kick-off Meeting VenueIndicates:“Medtronic is‘China Strategy3.0’Embrace the AI era comprehensively. We will leverage the Medtronic Beijing Digital Health Innovation Center (BDIC) as a key pivot, fully leverage China’s local data resources and ecosystem advantages to deeply drive the reshaping of the healthcare value chain and digital innovation, accelerating the development and implementation of outcomes within the local medical innovation ecosystem.”

As a key initiative in Medtronic’s deepened localization strategy, Mai’an at2021Established in Shanghai Lingang in [Year], isThe Only High-End Intelligent Manufacturing Base for Cardiac Pacemakers Established by a Multinational Corporation in China。2025By the end of the year, for the treatment of bradycardiaMaiAmmoniumNuPaceSeries of Implantable Cardiac PacemakersOfficially approved for market launch,2026Year4In June, the first batch of clinical implants was completed. The approval for market launch was closely aligned with clinical application, achieving a significant leap from platform development to product commercialization.

MaiAnNuPaceSeries of Implantable Cardiac Pacemakers

Medtronic Condi Integrated Surgical BaseAs a pioneer in the local intelligent manufacturing chain, from its research and development, design to productionSurgical Electric Endoscopic Stapler, currently, in addition to serving the Chinese market,AlsoHas been sold to multiple overseas markets, including France, Austria, and Spain, committed to achieving“Localization of High-End Technologies, Globalization of Local Innovations”value cycle.

Medtronic Condi Integrated Surgical Base, Electric Endoscopic Stapler

In the fields of orthopedics and neurosurgery, Medtronic Kanghui Changzhou Science and Technology ParkAiBLE™ Digital Intelligence Innovation Ecosystemas the core, continuously advancing the research and development of advanced medical technologies and enhancing high-end manufacturing capabilities. As another representative of intelligent manufacturing in China going global,NIM‑ECLIPSEIntraoperative Neuromonitoring Systems Are Being Successively Introduced into South Korea, Singapore, Bangladesh, and Other Countries and Regions.

Xu Bangda, Vice President of Commercial Operations for Medtronic China’s Orthopedics and Neurosurgery businesses, stated:“In the fields of orthopedics and neurosurgery, the evolution from ‘single-point technology’ to a ‘full-process ecosystem’ has become an inevitable trend.”AiBLE™ The Shuzhi Innovation Ecosystem deeply integrates Medtronic’s global innovative technologies with Kanghui’s localized R&D and manufacturing capabilities. ThroughAI“Leveraging big data to break down device barriers and enable cross-system collaboration, empowering physicians with more precise preoperative planning, more efficient intraoperative execution, and smarter postoperative management.”

AiBLE™ Digital Intelligence Innovation Ecosystem

In China, intracranial atherosclerotic lesions are one of the important causes of acute large vessel occlusion in the brain leading to ischemic stroke.MeilutongFRis a domestically produced, detachable intracranial thrombectomy stent that can be applied in the treatment of such patients. After successful thrombus removal and confirmation of blood flow restoration, the physician can actively release the stent from the delivery system and leave it indwelling within the vessel (i.e.,“release”), enabling an integrated procedure for thrombectomy and stent deployment, objectively reducing the need for repeated interventional procedures or the use of additional devices, thereby helping to alleviate the patient burden.

MeilutongFRIntracranial Thrombectomy Stent

03

From Digital Base to7000Domestic Suppliers

MedtronicCo-building an Open, Local Innovation Ecosystem

What Medtronic is doing in China is no longer just bringing global technologies in, but allowing new technologies to take root here and then extend globally.

Rooted in China for nearly40In recent years, Medtronic has actively integrated into and promoted the development of China’s local healthcare ecosystem, establishing an end-to-end local value chain spanning R&D, manufacturing, clinical training, services, and investment. This local value chain is undergoing comprehensive upgrading.，From“Single-Point Innovation”Steering“System Innovation”。

The foundation for Medtronic’s deep roots in the Chinese market lies not only in its localized innovation system with global reach but also in its comprehensive supply chain ecosystem, built through long-term collaboration and symbiotic partnerships with local stakeholders.

Medtronic has been developing in China for nearly7000Domestic Supply Chain Partners。2026In the fiscal year, Medtronic's total procurement in China was approximately57billion yuan. Among them,90%indirect procurement is sourced from local suppliers; in terms of direct procurement for key components, raw materials, and contract manufacturing, approximately90%locally sourced materials in China are supplied to Medtronic’s global factories. This means that China is not only a sales market for Medtronic, but also a deeply embedded node in its global supply chain.

2025In 2025, Medtronic partnered with local business travel partners to optimize travel management models through digital technology and intelligent data analysis. Leveraging the digital carbon emission monitoring capabilities of its supplier platform, the company achieved a cumulative reduction of approximately500Tons of carbon emission reduction.

Amidst a complex and ever-changing global market environment and growing domestic demand in China, Medtronic has built an open, efficient, and sustainable local healthcare innovation ecosystem in China, leveraging its world-leading innovative technological advantages and deeply vertical supply chain capabilities. Within this ecosystem, Medtronic is transitioning from a participant to a co-builder, collaborating with various stakeholders to continuously strengthen the foundation of innovation in China’s healthcare industry.